The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institutes for Medical Research and Molecular Medicine to recognize biomedical scientists whose discoveries have transformed the way medicine is practiced. The awardees are mid-career researchers who have made a significant impact in the understanding of human disease pathogenesis and/or treatment. Moreover, it is anticipated that they will continue to make profound advances in the general field of molecular medicine. To submit a 2023 Ross Prize nominee, click here.
The 2022 Ross Prize in Molecular Medicine will be awarded to Dr. Katalin Karikó, PhD, and Dr. Drew Weissman, MD, PhD, for their pioneering research on messenger RNA (mRNA) technology, which set the stage for the rapid use of the mRNA platform in the development of several COVID-19 vaccines.
Dr. Karikó and Dr. Weissman’s important foundational research is grounded in a decades-long partnership that overcame obstacles and skepticism. Their perseverance and innovation not only led to critical vaccines for the COVID-19 pandemic but hold much promise for a universal coronavirus vaccine and vaccines for other infectious diseases and chronic conditions.